The Canadian Press on MSN
Novo Nordisk considers competing with generics through renamed lower-price Ozempic
Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing ...
It sits in millions of American pantries right now—a mundane item that instantly reveals which side of the economic divide ...
Emmaus Life Sciences has entered into an agreement to sell the North American rights to its oral sickle cell disease ...
In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...
Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...
Generic drugs are supposed to be equivalent to brand-name medications — but the FDA doesn’t always ensure that.
The Canadian Press on MSN
Companies can make generic Ozempic as of next week, but don't expect to get it soon
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...
Emmaus has granted NeoImmuneTech Inc. an exclusive license to all rights to market, sell and distribute Endari and any ...
Consumers are being encouraged to abandon pricey branded medicines from chemists, as there's a straightforward method to achieve the same results while spending less money. Flu cases are climbing, ...
Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...
RALEIGH, N.C., Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company committed to improving access to affordable medicines, today announced the launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results